| 10008598 |
11(12)-EET Ethanolamide
|
|
- |
≥98%
|
|
|
2007-01-16
|
26.410596685083
|
11-12-eet-ethanolamide
|
11(12)-EpETrE Ethanolamide
|
AEA endocannabinoids Arachidonoyl ethanolamides CYP450 cytochromes metabolism neurochemistry anxiety depression 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide anandamides lipids neurotransmitters cannabinergic cannabinoids CBs FAAH inhibitor fatty acids hydrolases cbs synthetic |
26.410596685083
|
| 10008599 |
14(15)-EET Ethanolamide
|
|
- |
≥95%
|
|
|
2006-08-07
|
22.645801104972
|
14-15-eet-ethanolamide
|
14(15)-EpETrE Ethanolamide; 14(15)-Epoxy Eicosatrienoyl Ethanolamide
|
CYP450 cytochrome P450 metabolites AEA arachidonoyl ethanolamides anandamide lipids neurotransmitter cannibinergic cannabinoid CB1 CB2 receptors enzymatic metabolism FAAH fatty acid amide hydrolases endocannabinoid neurochemistry anxiety depression neuroscience 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cbs synthetic cannabinoids |
22.645801104972
|
| 10010132 |
15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester
|
|
- |
≥98% (isomer mixture)
|
|
|
2008-06-09
|
19.581055862492
|
15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester
|
15-deoxy-Δ12,14-PGJ2-2-glycerol ester
|
PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic |
19.581055862492
|
| 10169 |
15(S)-HETE Ethanolamide
|
|
161744-53-2 |
≥98%
|
|
|
|
19.370883977900
|
15-s-hete-ethanolamide
|
15(S)-HAEA
|
neurotransmitters ethanolamides fatty acids endocannabinoids CB receptors amide hydrolases FAAH neurochemistry neuroscience ethanolamines 15HETE cannabinoids cbs synthetic |
19.370883977900
|
| 362152 |
1-Arachidonoyl Glycerol-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
|
36.490704419889
|
1-arachidonoyl-glycerol-d5
|
1-AG-d5
|
deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic |
36.490704419889
|
| 10009962 |
2-(14,15-Epoxyeicosatrienoyl) Glycerol
|
|
848667-56-1 |
≥95%
|
|
|
2008-04-03
|
39.494825046040
|
2-14-15-epoxyeicosatrienoyl-glycerol
|
2-14,15-EG
|
2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids cannabinoids cbs synthetic |
39.494825046040
|
| 62160 |
2-Arachidonoyl Glycerol
|
|
53847-30-6 |
>95% (as a 9:1 mixture of the 2-AG and 1-AG)
|
|
|
|
43.426339384372
|
2-arachidonoyl-glycerol
|
2-AG
|
endocannabinoids anandamides 2AG fatty acids CB1 neuroscience neurochemistry endocrinology cannabinoids cbs synthetic |
43.426339384372
|
| 362162 |
2-Arachidonoyl Glycerol-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
|
47.930980662983
|
2-arachidonoyl-glycerol-d5
|
2-AG-d5
|
deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic |
47.930980662983
|
| 362160 |
2-Arachidonoyl Glycerol-d8
|
|
- |
≥99% deuterated forms (d1-d8)
|
|
|
|
84.020801104972
|
2-arachidonoyl-glycerol-d8
|
2-AG-d8
|
deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic |
84.020801104972
|
| 62165 |
2-Arachidonyl Glycerol ether
|
|
222723-55-9 |
>98%
|
|
|
|
32.466556169429
|
2-arachidonyl-glycerol-ether
|
Noladin; 2-AG ether
|
endocannabinoids 2AG anandamides CB1 receptor selective selectivity agonists stable 2-AG-ether analogs fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic |
32.466556169429
|
| 62260 |
2-Linoleoyl Glycerol
Exclusive
|
|
3443-82-1 |
>98%
|
|
✓ |
|
18.476045777426
|
2-linoleoyl-glycerol
|
2-LG
|
CB1 glycerols 2LG cannabinoids 2-Linoleoyl-Glycerol reuptake endocannabinoids receptors congeners fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic |
18.476045777426
|
| 10008596 |
5(6)-EET Ethanolamide
|
|
- |
≥95%
|
|
|
2006-10-20
|
9.080923441200
|
5-6-eet-ethanolamide
|
5(6)-EpETrE Ethanolamide
|
epoxides epoxygenases 5,6-EETs cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs fatty acids esters ethanolamides metabolites AEA anandamides arachidonoyl neurotransmitters cannabinergic endocannabinoids CB1 CB2 receptors central peripheral FAAH hydrolases metabolism lipoxygenases inhibition (±)5(6)-Epoxy eicosatrienoyl 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cannabinoids cbs synthetic |
9.080923441200
|
| 10008597 |
8(9)-EET Ethanolamide
|
|
- |
≥98%
|
|
|
2007-07-05
|
17.391712707182
|
8-9-eet-ethanolamide
|
8(9)-EpETrE Ethanolamide
|
AEA endocannabinoids arachidonoyl ethanolamide CYP450 cytochrome P450 metabolism ethanolamides hypertension cannabinoids cbs synthetic |
17.391712707182
|
| 10180 |
Arachidonoyl Ethanolamide Phosphate
|
|
183323-26-4 |
>98%
|
|
|
2004-08-19
|
21.402127071823
|
arachidonoyl-ethanolamide-phosphate
|
AEA-P; Anandamide Phosphate
|
endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors fatty acids phosphates anandamides LPA lysophosphatidic ethanolamines ethanolamides cannabinoids cbs synthetic |
21.402127071823
|
| 10007293 |
Arachidonoyl-N,N-dimethyl amide
|
|
45280-17-9 |
>98%
|
|
|
2006-01-11
|
6.736053670087
|
arachidonoyl-n-n-dimethyl-amide
|
Arachidonic Acid-N,N-dimethyl amide
|
anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience cannabinoids cbs synthetic |
6.736053670087
|
| 62170 |
Arachidonoyl Serinol
|
|
183718-70-9 |
>98%
|
|
|
|
37.453093922652
|
arachidonoyl-serinol
|
|
endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience cannabinoids cbs synthetic |
37.453093922652
|
| 10005765 |
Arachidoyl Ethanolamide
Exclusive
|
|
94421-69-9 |
>98%
|
|
✓ |
2005-06-22
|
13.890865561694
|
arachidoyl-ethanolamide
|
N-Arachidoylethanolamine
|
arachidoyls ethanolamides N-acyls saturated anandamides analogs enocannabinoids CB1 CB2 memory weight loss appetite neurodegeneration tumors arachidoylethanolamide surveillance analgesia inflammations fatty hydrolytic enzymes FAAH acid amides hydrolases AEA neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
13.890865561694
|
| 90235 |
Dihomo-γ-Linolenoyl Ethanolamide
|
|
150314-34-4 |
>98%
|
|
|
|
6.899275268118
|
dihomo-linolenoyl-ethanolamide
|
|
endocannabinoids neurotransmitters dihomo-gamma-linolenoyl dihomo-g-linolenoyl dihomo-.gamma.-linolenoyl cannabinergic fatty acids neurochemistry neuroscience ethanolamines ethanolamides cannabinoids cbs synthetic |
6.899275268118
|
| 10007534 |
Docosahexaenoyl Ethanolamide
Exclusive
|
|
162758-94-3 |
≥98%
|
|
✓ |
2006-02-17
|
20.422555781719
|
docosahexaenoyl-ethanolamide
|
DHEA; DEA
|
neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA |
20.422555781719
|
| 9001108 |
Docosahexaenoyl Ethanolamide-d4
Exclusive New
|
|
946524-43-2 |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2012-02-21
|
19.810945429872
|
docosahexaenoyl-ethanolamide-d4
|
DHEA-d4; DEA-d4
|
neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry LC/MS MS |
19.810945429872
|
| 10005823 |
Docosanoyl Ethanolamide
Exclusive
|
|
94109-05-4 |
≥98%
|
|
✓ |
2006-01-11
|
12.658242803140
|
docosanoyl-ethanolamide
|
|
neurochemistry neuroscience N-acylethanolamides cannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation saturated ion channels ethanolamines cbs synthetic |
12.658242803140
|
| 90385 |
Docosatetraenoyl Ethanolamide
|
|
150314-35-5 |
≥98%
|
|
|
|
6.723041923952
|
docosatetraenoyl-ethanolamide
|
DEA
|
endocannabinoids neurotransmitters ethanolamides docosatetraenoic acid fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
6.723041923952
|
| 10964 |
Eicosapentaenoyl Ethanolamide
|
|
109001-03-8 |
≥98%
|
|
|
2011-06-22
|
57.375516969219
|
eicosapentaenoyl-ethanolamide
|
EPEA
|
cannabinoids CBSs endocannabinoids forensic sciences signals signaling N-acylethanolamide N-acylethanolamine NAE dietary restrictions lifespans TOR nematodes eicosapentaenoic acids inflammation anti-inflammatory |
57.375516969219
|
| 10011347 |
Glycerophospho-N-Arachidonoyl Ethanolamine
Exclusive
|
|
201738-25-2 |
≥97%
|
|
✓ |
2009-03-13
|
18.765230202578
|
glycerophospho-n-arachidonoyl-ethanolamine
|
Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE
|
anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic |
18.765230202578
|
| 10011357 |
Glycerophospho-N-Oleoyl Ethanolamine
Exclusive
|
|
201738-24-1 |
≥98%
|
|
✓ |
2009-02-20
|
24.612817679558
|
glycerophospho-n-oleoyl-ethanolamine
|
|
cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic |
24.612817679558
|
| 10006371 |
Hormone Sensitive Lipase Polyclonal Antibody
|
|
- |
|
|
|
2005-06-22
|
9.506293738489
|
hormone-sensitive-lipase-polyclonal-antibody
|
HSL; LIPE
|
proteins antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry catalyses hydrolysis of tri- di- monoacylglycerols cholesterol esters mobilizes fatty acids primary source energy mammals enzyme expressed adipose tissues stearidonic steroidgenesis spermatogenesis foam cell formation atherosclerosis diabetic pathology human cDNA isoforms testis mRNA mouse murine macrophages testicular ram seminal vesicles triacylglycerols diacylglycerols atherosclerosis |
9.506293738489
|
| 10008661 |
JP104
Exclusive
|
|
- |
≥98%
|
|
✓ |
2006-09-05
|
7.391034655951
|
jp104
|
|
click chemistry probes FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB598 acyl anandamide AEA esters unsaturated carbamates neurochemistry |
7.391034655951
|
| 90155 |
Linoleoyl Ethanolamide
|
|
68171-52-8 |
>98%
|
|
|
|
4.542530386740
|
linoleoyl-ethanolamide
|
|
cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl cbs synthetic |
4.542530386740
|
| 9000553 |
Linoleoyl Ethanolamide-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2010-01-13
|
2.351657458564
|
linoleoyl-ethanolamide-d4
|
|
cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS cbs synthetic |
2.351657458564
|
| 10005455 |
N-Arachidonoyl-L-Serine
|
|
187224-29-9 |
>98%
|
|
|
2004-08-11
|
7.062702159718
|
n-arachidonoyl-l-serine
|
ARA-S
|
endocannabinoids antagonists cannabidiols neuroprotective neurotransmitters hypotensive effects antagonize antagonist neurochemistry neuroscience cannabinoids cbs synthetic |
7.062702159718
|
| 10005537 |
N-Arachidonoyl Taurine
Exclusive
|
|
- |
>98%
|
|
✓ |
2004-11-18
|
7.087296764009
|
n-arachidonoyl-taurine
|
|
bovine brain NADA dopamine ARA-S ARAS N-arachidonoyl-L-serine lipidomics mass spectrometry MS rats N-fatty acyl amides amino acids neurochemistry neuroscience TRPV1 TRPV4 FAAH, cbs, cannabinoids, synthetic |
7.087296764009
|
| 10007517 |
N-Arachidonyl Maleimide
|
|
876305-42-9 |
>98%
|
|
|
2006-07-31
|
18.778762430939
|
n-arachidonyl-maleimide
|
NAM
|
neurochemistry neuroscience 2-AG 2-arachidonoyl glycerol MGL MAGL monoacylglycerol lipase monoglycerol inhibition inhibits inhibitor pain inflammation anxiety endocannabinoids anandanides 2AG fatty acids CB1 CB2 central peripheral inhibitors cannabinoids cbs synthetic |
18.778762430939
|
| 10007288 |
N-Docosanoyl Taurine
|
|
- |
≥98%
|
|
|
2005-12-29
|
0.491139502762
|
n-docosanoyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.491139502762
|
| 10007286 |
N-Lignoceroyl Taurine
|
|
807370-75-8 |
>98%
|
|
|
2005-12-21
|
0.529526440410
|
n-lignoceroyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.529526440410
|
| 10007287 |
N-Nervonoyl Taurine
|
|
- |
>98%
|
|
|
2005-12-29
|
0.529526440410
|
n-nervonoyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.529526440410
|
| 10115 |
N-Oleoyl Dopamine
|
|
105955-11-1 |
≥98%
|
|
|
|
5.504001578531
|
n-oleoyl-dopamine
|
ODA
|
VR1 agonists CB1 receptors analogs vanilloids cannabinoids analgesic amides N-oleoyldopamine inhibits inhibitors inhibition 5-lipoxygenases 5-LOs binding selective FAAH hydrolases fatty acid neurochemistry neuroscience cbs synthetic |
5.504001578531
|
| 13058 |
N-Oleoyl-L-Serine
|
|
- |
≥98%
|
|
|
2008-10-17
|
1.935911602210
|
n-oleoyl-l-serine
|
|
lipids bones endogenous anabolic activity activities formation resorption cannabinoids cbs synthetic |
1.935911602210
|
| 10005609 |
N-Oleoyl Taurine
Exclusive
|
|
52514-04-2 |
≥98%
|
|
✓ |
2005-01-05
|
7.001404235727
|
n-oleoyl-taurine
|
|
endocannibinoids fatty amides oleamides taurines amino-acyls lipidomics profiling fatty acids neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
7.001404235727
|
| 10007697 |
N-Palmitoyl Dopamine
|
|
136181-87-8 |
>98%
|
|
|
2005-11-23
|
5.079447513812
|
n-palmitoyl-dopamine
|
PALDA
|
N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic |
5.079447513812
|
| 10005611 |
N-Palmitoyl Taurine
|
|
83982-06-3 |
>98%
|
|
|
2005-02-16
|
6.738441199684
|
n-palmitoyl-taurine
|
|
endocannabinoids fatty amides oleamides bovine brain lipidomics rat amino-acyl neurochemistry, cannabinoids cbs synthetic |
6.738441199684
|
| 10005610 |
N-Stearoyl Taurine
|
|
63155-80-6 |
>98%
|
|
|
2005-02-09
|
6.968275453828
|
n-stearoyl-taurine
|
|
endocannabinoids fatty amides oleamides amino-acyl bovine brain rat lipidomics neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
6.968275453828
|
| 91050 |
O-Arachidonoyl Ethanolamine (hydrochloride)
|
|
443129-35-9 |
>98%
|
|
|
|
35.874988950276
|
o-arachidonoyl-ethanolamine-hydrochloride
|
Virodhamine; O-AEA; Arachidonic Acid-(2-aminoethyl)-ester
|
endocannabinoids anandamides tetrahydrocannabinoids THC CB1 CB2 receptors arachidonoyl ethanolamides ligand ethanolamines neurochemistry neuroscience esters antagonists cannabinoids cbs synthetic |
35.874988950276
|
| 90265 |
Oleoyl Ethanolamide
|
|
111-58-0 |
≥98%
|
|
|
|
19.863959484346
|
oleoyl-ethanolamide
|
Oleic Acid Ethanolamide; OEA
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
19.863959484346
|
| 10007823 |
Oleoyl Ethanolamide-d2
|
|
- |
≥99% deuterated forms (d1-d2)
|
|
|
2006-03-06
|
17.913535911602
|
oleoyl-ethanolamide-d2
|
OEA-d2; Oleic Acid Ethanolamide-d2
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
17.913535911602
|
| 9000552 |
Oleoyl Ethanolamide-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1- d4)
|
|
✓ |
2010-01-12
|
10.248737174428
|
oleoyl-ethanolamide-d4
|
Oleic Acid Ethanolamide-d4; OEA-d4
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic |
10.248737174428
|
| 10005459 |
Oleoyl Ethyl Amide
Exclusive
|
|
85075-82-7 |
>98%
|
|
✓ |
2004-07-21
|
22.870906077348
|
oleoyl-ethyl-amide
|
N-Ethyloleamide; OEtA
|
endocannabinoids analogs FAAH fatty acid amide hydrolase analgesic inhibitors inhibitor inhibition acyl PEAase anxiolytic inhibits selective selectivity neuroscience neurochemistry cannabinoids cbs synthetic |
22.870906077348
|
| 10965 |
Palmitoleoyl Ethanolamide
|
|
94421-67-7 |
≥98%
|
|
|
2011-06-27
|
20.839465930018
|
palmitoleoyl-ethanolamide
|
POEA
|
cannabinoids endocannabinoids CBs N-acylethanolamines signalling N-acylethanolamides NAEs signaling receptors pain lipid-derived |
20.839465930018
|
| 90350 |
Palmitoyl Ethanolamide
|
|
544-31-0 |
≥98%
|
|
|
|
13.010110497237
|
palmitoyl-ethanolamide
|
Palmidrol; PEA
|
endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
13.010110497237
|
| 10007824 |
Palmitoyl Ethanolamide-d4
Exclusive
|
|
1159908-45-8 |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2006-03-06
|
12.649668508287
|
palmitoyl-ethanolamide-d4
|
Palmidrol-d4; PEA-7,7,8,8-d4
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines cannabinoids cbs synthetic |
12.649668508287
|
| 9000551 |
Palmitoyl Ethanolamide-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2010-01-20
|
6.165601157590
|
palmitoyl-ethanolamide-d4
|
Palmidrol-d4; PEA-hydroxyethyl-1,1,2,2-d4
|
endocannabinoids CB2 neurotransmitters receptors ligands PEAs N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS cannabinoids cbs synthetic |
6.165601157590
|
| 9000573 |
Palmitoyl Ethanolamide-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2010-03-04
|
5.393704726826
|
palmitoyl-ethanolamide-d5
|
PEA-15,15,16,16,16-d5; Palmidrol-d5
|
endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS CBs synthetic |
5.393704726826
|
| 62175 |
Palmitoyl Serinol
|
|
126127-31-9 |
>98%
|
|
|
|
21.019765193370
|
palmitoyl-serinol
|
|
endocannabinoids 2PG CB1 receptors synthases FAAH fatty acids amides analogs hydrolases 2-PG glycerols adenyl cyclase inhibits inhibition re-uptake reuptake neurochemistry neuroscience cannabinoids cbs synthetic |
21.019765193370
|
| 12015 |
Prostaglandin D2-1-glyceryl ester
|
|
309260-52-4 |
>95% (as a 9:1 mixture of the 1- and 2-glyceryl esters)
|
|
|
2004-08-05
|
35.810524861878
|
prostaglandin-d2-1-glyceryl-ester
|
PGD2-1-glyceryl ester
|
endocannabinoids anandamides 2AG fatty acids porcine brain isomerase moiety cannabinoids cbs synthetic |
35.810524861878
|
| 10140 |
Prostaglandin E2-1-glyceryl ester
|
|
37497-47-5 |
>98% (as a 85:15 mixture of the 1- and 2-glyceryl esters)
|
|
|
|
50.722817679558
|
prostaglandin-e2-1-glyceryl-ester
|
PGE2-1-glyceryl ester
|
Prostaglandins PGE2-1-GE esters 2-AG 2-arachidonyl-glycerol metabolites COX-2 PGHS-2 cycloxygenases synthases PGE2-2-GE COX2 PGHS2 cannabinoids cbs synthetic |
50.722817679558
|
| 10139 |
Prostaglandin F2α-1-glyceryl ester
|
|
43042-79-1 |
>98% (as a 9:1 mixture of the 2- and 1-glyceryl esters)
|
|
|
|
17.860110497238
|
prostaglandin-f2-1-glyceryl-ester
|
PGF2α-1-glyceryl ester
|
Prostaglandins PGF2alpha-1-GE PGF2.alpha.-1-GE esters 2-AG 2-arachidonoyl-glycerol COX-2 metabolites cyclooxygenases PGHS-2 synthases PGHS2 COX2 PGF2alpha-2-GE PGF2.alpha.-2-GE PGFa-2-GE PGF2a-1-GE cannabinoids cbs synthetic |
17.860110497238
|
| 10004281 |
R-1 Methanandamide Phosphate
|
|
- |
>98%
|
|
|
2004-08-20
|
21.225856353591
|
r-1-methanandamide-phosphate
|
R-1MAP; (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate
|
endocannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors anandamides analogs agonists phosphates LPA lysophatidic acids neurochemistry neuroscience R1 cannabinoids cbs synthetic |
21.225856353591
|
| 90215 |
α-Linolenoyl Ethanolamide
Exclusive
|
|
57086-93-8 |
>98%
|
|
✓ |
|
9.920122336227
|
-linolenoyl-ethanolamide
|
|
cannabinoids neurotransmitters ethanolamides fatty acids CB alpha-linolenoyl .alpha.-linolenoyl cannabinergic neurochemistry neuroscience ethanolamines, cbs, synthetic |
9.920122336227
|